Literature DB >> 25374179

Silencing of NUF2 inhibits tumor growth and induces apoptosis in human hepatocellular carcinomas.

Qiang Liu1, She-Jiao Dai, Hong Li, Lei Dong, Yu-Ping Peng.   

Abstract

BACKGROUND: As an important component of the NDC80 kinetochore complex, NUF2 is essential for kinetochore-microtubule attachment and chromosome segregation. Previous studies also suggested its involvement in development of various kinds of human cancers, however, its expression and functions in human hepatocellular carcinoma (HCC) are still unclear.
MATERIALS AND METHODS: In the present study, we aimed to test the hypothesis that NUF2 is aberrant in human HCCs and associated with cell growth.
RESULTS: Our results showed significantly elevated expression of NUF2 in human HCC tissues compared to adjacent normal tissues, and high expression of NUF2 in HCC cell lines. Using lentivirus-mediated silencing of NUF2 in HepG2 human HCC cells, we found that NUF2 depletion markedly suppressed proliferation and colony formation capacity in vitro, and dramatically hampered tumor growth of xenografts in vivo. Moreover, NUF2 silencing could induce cell cycle arrest and trigger cell apoptosis. Additionally, altered levels of cell cycle and apoptosis related proteins including cyclin B1, Cdc25A, Cdc2, Bad and Bax were also observed.
CONCLUSIONS: In conclusion, these results demonstrate that NUF2 plays a critical role in the regulation of HCC cell proliferation and apoptosis, indicating that NUF2 may serve as a potential molecular target for therapeutic approaches.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25374179     DOI: 10.7314/apjcp.2014.15.20.8623

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  21 in total

1.  Comprehensive assessment of cancer missense mutation clustering in protein structures.

Authors:  Atanas Kamburov; Michael S Lawrence; Paz Polak; Ignaty Leshchiner; Kasper Lage; Todd R Golub; Eric S Lander; Gad Getz
Journal:  Proc Natl Acad Sci U S A       Date:  2015-09-21       Impact factor: 11.205

2.  [Expression of NUF2 in breast cancer and its clinical significance].

Authors:  Jingbo Sun; Jiawei Chen; Zhizhi Wang; Yunyao Deng; Lixin Liu; Xiaolong Liu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-05-30

3.  Evaluation of NUF2 and GMNN Expression in Prostate Cancer: Potential Biomarkers for Prostate Cancer Screening.

Authors:  Shaghayegh Pezeshki; Payam Hashemi; Alireza Salimi; Sheida Ebrahimi; Mandana Javanzad; Amir Monfaredan
Journal:  Rep Biochem Mol Biol       Date:  2021-07

4.  The roles of the cell division cycle-associated gene family in hepatocellular carcinoma.

Authors:  Qiang Tao; Siliang Chen; Jia Liu; Peng Zhao; Lingmin Jiang; Xinyue Tu; Xiang Tang; Zonghao Liu; Abudoukeyimu Yasheng; Kahaer Tuerxun; Yun Zheng
Journal:  J Gastrointest Oncol       Date:  2021-04

5.  Poly-SUMO-2/3 chain modification of Nuf2 facilitates CENP-E kinetochore localization and chromosome congression during mitosis.

Authors:  Divya Subramonian; Te-An Chen; Nicholas Paolini; Xiang-Dong David Zhang
Journal:  Cell Cycle       Date:  2021-04-28       Impact factor: 4.534

6.  A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.

Authors:  Pengpeng Zhu; Junfei Jin; Yan Liao; Jun Li; Xue-Zhong Yu; Weijia Liao; Songqing He
Journal:  Oncotarget       Date:  2015-12-01

7.  Eleven genes associated with progression and prognosis of endometrial cancer (EC) identified by comprehensive bioinformatics analysis.

Authors:  JinHui Liu; ShuLin Zhou; SiYue Li; Yi Jiang; YiCong Wan; XiaoLing Ma; WenJun Cheng
Journal:  Cancer Cell Int       Date:  2019-05-20       Impact factor: 5.722

8.  Edgetic perturbation signatures represent known and novel cancer biomarkers.

Authors:  Evans Kataka; Jan Zaucha; Goar Frishman; Andreas Ruepp; Dmitrij Frishman
Journal:  Sci Rep       Date:  2020-03-09       Impact factor: 4.379

9.  Quantitative proteomic analysis reveals that Luks-PV exerts antitumor activity by regulating the key proteins and metabolic pathways in HepG2 cells.

Authors:  Chang-Cheng Zhao; Wen-Wei Yu; Ying-Jie Qi; Liang-Fei Xu; Zi-Ran Wang; Ya-Wen Qiang; Fan Ma; Xiao-Ling Ma
Journal:  Anticancer Drugs       Date:  2020-03       Impact factor: 2.389

10.  Potential therapeutic targets of the nuclear division cycle 80 (NDC80) complexes genes in lung adenocarcinoma.

Authors:  Zhong-Yi Sun; Wei Wang; Han Gao; Quan-Fang Chen
Journal:  J Cancer       Date:  2020-03-04       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.